Automate Your Wheel Strategy on BSX
With Tiblio's Option Bot, you can configure your own wheel strategy including BSX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BSX
- Rev/Share 12.5086
- Book/Share 15.3216
- PB 6.4388
- Debt/Equity 0.5365
- CurrentRatio 1.3721
- ROIC 0.0701
- MktCap 144663412027.0
- FreeCF/Share 2.2394
- PFCF 43.6918
- PE 57.6922
- Debt/Assets 0.2894
- DivYield 0
- ROE 0.1149
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | BSX | Oppenheimer | Perform | Outperform | -- | $125 | Sept. 8, 2025 |
| Initiation | BSX | Leerink Partners | -- | Outperform | -- | $118 | June 16, 2025 |
| Upgrade | BSX | Needham | Hold | Buy | -- | $113 | April 16, 2025 |
| Upgrade | BSX | Deutsche Bank | Hold | Buy | -- | $108 | Jan. 10, 2025 |
| Downgrade | BSX | Needham | Buy | Hold | -- | -- | Oct. 18, 2024 |
News
Here is Why Growth Investors Should Buy Boston Scientific (BSX) Now
Published: April 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific (BSX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
Boston Scientific (BSX) Upgraded to Buy: Here's What You Should Know
Published: April 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Read More
Here's Why Boston Scientific (BSX) is a Strong Momentum Stock
Published: April 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year?
Published: April 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Here is how Boston Scientific (BSX) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.
Read More
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term
Published: April 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Boston Scientific Corporation (BSX) Q1 2025 Earnings Call Transcript
Published: April 23, 2025 by: Seeking Alpha
Sentiment: Neutral
Boston Scientific Corporation (NYSE:BSX ) Q1 2025 Results Conference Call April 23, 2025 8:00 AM ET Company Participants Jon Monson - Senior Vice President, Investor Relations Mike Mahoney - Chairman and Chief Executive Officer Dan Brennan - Executive Vice President and Chief Financial Officer Ken Stein - Chief Medical Officer Conference Call Participants Robbie Marcus - JPMorgan Larry Biegelsen - Wells Fargo Joanne Wuensch - Citi Rick Wise - Stifel David Roman - Goldman Sachs Travis Steed - Bank of America Patrick Wood - Morgan Stanley Danielle Antalffy - UBS Josh Jennings - TD Cowen Michael Polark - Wolfe Research …
Read More
BSX Q1 Earnings & Revenues Beat, Stock Up, 2025 View Raised
Published: April 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific's first-quarter 2025 performance benefits from the strength of its product portfolio.
Read More
Boston Scientific Stock Surges on Strong Results, Outlook; CFO To Retire
Published: April 23, 2025 by: Investopedia
Sentiment: Positive
Shares of Boston Scientific (BSX) rose sharply Wednesday after the firm posted first-quarter results that topped analysts' estimates.
Read More
Should You Buy Boston Scientific Stock Ahead of Q1 Earnings?
Published: April 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Banking on robust above-market growth across all business units, BSX is expected to have witnessed strong international momentum in the first quarter.
Read More
PAHC or BSX: Which Is the Better Value Stock Right Now?
Published: April 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Boston Scientific (BSX) Surges 6.8%: Is This an Indication of Further Gains?
Published: April 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific (BSX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Read More
Here's Why Boston Scientific (BSX) is a Strong Growth Stock
Published: April 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
3 Stocks to Buy for "Liberation" From Trump Tariffs & Recession Woes
Published: April 02, 2025 by: Zacks Investment Research
Sentiment: Neutral
In 2025, companies like MASI, BSX and HIMS are expected to overcome challenges and sustain strong growth and market leadership.
Read More
PAHC vs. BSX: Which Stock Is the Better Value Option?
Published: March 31, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
International Expansion, Product Launches Support BSX Stock
Published: March 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific continues to successfully expand its operations across various geographies outside the United States.
Read More
The Zacks Analyst Blog Boston Scientific, Abbott and Medtronic
Published: March 25, 2025 by: Zacks Investment Research
Sentiment: Neutral
Boston Scientific, Abbott and Medtronic are included in this Analyst Blog.
Read More
Fed's Stagflation Fears Weigh, Yet Growth Factors Make BSX Stock a Buy
Published: March 24, 2025 by: Zacks Investment Research
Sentiment: Negative
Boston Scientific, with substantial operations in China and Europe, faces significant risks due to escalating global trade tensions in 2025.
Read More
Watch These 5 AI-Powered Healthcare Bigwigs for Portfolio Gains
Published: March 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Five AI-powered stocks have strong revenues and earnings growth potentials for 2025. These are: MDT, LLY, BSX, NVS, ABT.
Read More
PAHC vs. BSX: Which Stock Should Value Investors Buy Now?
Published: March 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?
Published: March 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors continue to be optimistic about BSX, courtesy of its international expansion efforts and WATCHMAN's performance.
Read More
Boston Scientific Gains 42.2% in a Year: What's Driving the Stock?
Published: March 11, 2025 by: Zacks Investment Research
Sentiment: Positive
BSX's shares rise on the back of its innovative product portfolio and impressive value-added acquisition. However, the unfavorable macroeconomic scenario is concerning.
Read More
Boston Scientific Corporation (BSX) TD Cowen 45th Annual Healthcare Conference (Transcript)
Published: March 04, 2025 by: Seeking Alpha
Sentiment: Neutral
Boston Scientific Corporation (NYSE:BSX ) TD Cowen 45th Annual Healthcare Conference March 4, 2025 9:10 AM ET Company Participants Dan Brennan - Chief Financial Officer Ken Stein - Chief Medical Officer Art Butcher - Executive Vice President, MedSurg and APAC Conference Call Participants Josh Jennings - TD Cowen Josh Jennings Good morning. I'm Josh Jennings from the TD Cowen Medical Devices research team, and joined by Brian Kennedy and Eric Anderson, and we're excited to kick off Day 2 of the 45th Annual TD Cowen Healthcare Conference and thrilled to have executives from the Boston Scientific management team joining us …
Read More
Why Boston Scientific (BSX) is a Top Momentum Stock for the Long-Term
Published: March 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Balloon Catheters Patent Landscape Report 2025, with Profiles of Cook Medical Technologies, Boston Scientific Scimed, Scimed Life Systems, Terumo Corp and Advanced Cardiovascular System
Published: February 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
Dublin, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The "Balloon Catheters Patent Landscape Report" has been added to ResearchAndMarkets.com's offering.
Read More
Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?
Published: February 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Here is how Boston Scientific (BSX) and Abivax SA Sponsored ADR (ABVX) have performed compared to their sector so far this year.
Read More
Boston Scientific Expects Strong Gains in 2025: Time to Buy the Stock?
Published: February 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific begins 2025 on a solid note, expecting organic revenue growth of 14% to 16% in the first quarter.
Read More
Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference
Published: February 19, 2025 by: PRNewsWire
Sentiment: Neutral
MARLBOROUGH, Mass. , Feb. 19, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 45th Annual Health Care Conference on Tuesday, March 4, 2025.
Read More
PBH or BSX: Which Is the Better Value Stock Right Now?
Published: February 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
EMEA Expansion to Support BSX Stock Amid Fierce Competition
Published: February 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific successfully continues with its expansion of operations across different geographies outside the United States.
Read More
The Zacks Analyst Blog The Procter & Gamble, Boston, ConocoPhillips and Kewaunee Scientific
Published: February 11, 2025 by: Zacks Investment Research
Sentiment: Neutral
The Procter & Gamble, Boston, ConocoPhillips and Kewaunee Scientific are included in this Analyst Blog.
Read More
About Boston Scientific Corporation (BSX)
- IPO Date 1992-05-19
- Website https://www.bostonscientific.com
- Industry Medical - Devices
- CEO Michael F. Mahoney
- Employees 53000